Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 15,08
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 16,84
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, CH, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 19,15
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. 1st ed. 2021.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 19,30
Cantidad disponible: 2 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, Cham, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Original o primera edición
EUR 21,86
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. This open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Human challenge studies (HCS) involve the intentional infection of research participants, and this type of research is rapidly increasing in frequency worldwide. HCS are widely considered to be an especially promising approach to vaccine development, including for pathogens endemic to LMICs. However, challenge studies are sometimes controversial and raise complex ethical issues, some of which are especially salient in endemic and/or LMIC settings. Informed by qualitative interviews with experts in infectious diseases and bioethics, this book highlights areas of ethical consensus and controversy concerning this kind of research. As the first volume to focus on ethical issues associated with human challenge studies, it sets the agenda for further work in this important area of global health research; contributes to current debates in research ethics; and aims to inform regulatory policy and research practice. Insofar as it focuses on HCS in (endemic) settings where diseases are present and/or widespread, much of the analysis provided here is directly relevant to HCS involving pandemic diseases including COVID19. This open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 17,11
Cantidad disponible: 2 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Librería: Chiron Media, Wallingford, Reino Unido
EUR 13,15
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 17,11
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Blue Vase Books, Interlochen, MI, Estados Unidos de America
EUR 33,32
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: very_good. Book has little sign of wear or use.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 16,07
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 18,58
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 34,79
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 198.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 44,43
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
EUR 43,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 35,72
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 152 pages. 9.25x6.10x0.35 inches. In Stock.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 49,78
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
EUR 52,53
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: Chiron Media, Wallingford, Reino Unido
EUR 44,49
Cantidad disponible: 10 disponibles
Añadir al carritoPF. Condición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 46,61
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 47,43
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, Cham, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: AussieBookSeller, Truganina, VIC, Australia
Original o primera edición
EUR 35,24
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. This open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Human challenge studies (HCS) involve the intentional infection of research participants, and this type of research is rapidly increasing in frequency worldwide. HCS are widely considered to be an especially promising approach to vaccine development, including for pathogens endemic to LMICs. However, challenge studies are sometimes controversial and raise complex ethical issues, some of which are especially salient in endemic and/or LMIC settings. Informed by qualitative interviews with experts in infectious diseases and bioethics, this book highlights areas of ethical consensus and controversy concerning this kind of research. As the first volume to focus on ethical issues associated with human challenge studies, it sets the agenda for further work in this important area of global health research; contributes to current debates in research ethics; and aims to inform regulatory policy and research practice. Insofar as it focuses on HCS in (endemic) settings where diseases are present and/or widespread, much of the analysis provided here is directly relevant to HCS involving pandemic diseases including COVID19. This open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Idioma: Inglés
Publicado por Springer International Publishing, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: moluna, Greven, Alemania
EUR 19,44
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. This open access book was solicited and funded by the Wellcome TrustProvides comprehensive coverage of research ethics and regulatory issues related to human challenge studiesThe first book on the ethics of human challenge studies, whic.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 52,52
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Speedyhen, Hertfordshire, Reino Unido
EUR 21,22
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: NEW.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 58,47
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 24,06
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This open access bookprovides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs).Human challenge studies (HCS) involve the intentional infection of research participants, and this type of research is rapidly increasing in frequency worldwide.HCS are widely considered to be an especially promising approach to vaccine development, including for pathogens endemic to LMICs. However, challenge studies are sometimes controversial and raise complex ethical issues, some of which are especially salient in endemic and/or LMIC settings.Informed by qualitative interviews with experts in infectious diseases and bioethics, this book highlights areas of ethical consensus and controversy concerning this kind of research. As the first volume to focus on ethical issues associated with human challenge studies, it sets the agenda for further work in this important area of global health research; contributes to current debates in research ethics; and aims to inform regulatory policy and research practice. Insofar as it focuses on HCS in (endemic) settings where diseases are present and/or widespread, much of the analysis provided here is directly relevant to HCS involving pandemic diseases including COVID19.
Idioma: Inglés
Publicado por Springer Nature Switzerland AG, CH, 2020
ISBN 10: 3030414795 ISBN 13: 9783030414795
Librería: Rarewaves.com UK, London, Reino Unido
EUR 16,06
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. 1st ed. 2021.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 82,29
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 465 pages. 9.25x6.10x1.00 inches. In Stock.
Idioma: Inglés
Publicado por Springer International Publishing, Springer International Publishing Aug 2021, 2021
ISBN 10: 303027876X ISBN 13: 9783030278762
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 42,79
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware -This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 468 pp. Englisch.
Idioma: Inglés
Publicado por Springer International Publishing, Springer International Publishing, 2021
ISBN 10: 303027876X ISBN 13: 9783030278762
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 42,79
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.